Leveraging real-world data to conduct externally controlled trial for rare diseases with count-type endpoints: utilizing multiple entries - a simulation study.
Saved in:
| Title: | Leveraging real-world data to conduct externally controlled trial for rare diseases with count-type endpoints: utilizing multiple entries - a simulation study. |
|---|---|
| Authors: | Sun T; Biometrics, Moderna, Inc., Cambridge, Massachusetts, USA., Liao E; Biometrics, Moderna, Inc., Cambridge, Massachusetts, USA., Shao N; Biometrics, Moderna, Inc., Cambridge, Massachusetts, USA., Luo J; Biometrics, Moderna, Inc., Cambridge, Massachusetts, USA. |
| Source: | Journal of biopharmaceutical statistics [J Biopharm Stat] 2026 May; Vol. 36 (3), pp. 337-349. Date of Electronic Publication: 2024 Oct 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9200436 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5711 (Electronic) Linking ISSN: 10543406 NLM ISO Abbreviation: J Biopharm Stat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1520-5711 |
|---|---|
| DOI: | 10.1080/10543406.2024.2420644 |
